MTA1 Overexpression Induces Cisplatin Resistance Innasopharyngeal Carcinoma by Promoting Cancer Stem Cells Properties |
Feng, Xiaohua
(Department of Otolaryngology, General Hospital of Guangzhou Command)
Zhang, Qianbing (Cancer Institute of Southern Medical University) Xia, Songxin (Department of stomatology, Guangdong Provincial Hospital of Traditional Chinese Medicine) Xia, Bing (Department of Cardiology, 458th Hospital of People's Liberation Army) Zhang, Yue (Department of Radiotherapy, Nanfang Hospital of Southern Medical University) Deng, Xubin (Department of Radiotherapy, Nanfang Hospital of Southern Medical University) Su, Wenmei (Cancer Center of Affiliated Hospital of Guangdong Medical College) Huang, Jianqing (Department of Medical Oncology, Affiliated Cancer Hospital of Guangzhou Medical University, Cancer Center of Guangzhou Medical University (CCGMU)) |
1 | Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., and Dirks, P.B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828. |
2 | Song, Q., Zhang, H., Wang, M., Song, W., Ying, M., Fang, Y., Li, Y., Chao, Y., and Zhu, X. (2013). MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo. J.Exp.Clin.Cancer Res. 32, 54. DOI ScienceOn |
3 | Spano, J.P., Busson, P., Atlan, D., Bourhis, J., Pignon, J.P., Esteban, C., and Armand, J.P. (2003). Nasopharyngeal carcinomas: an update. Eur. J.Pharmacol. 39, 2121-2135. |
4 | Venkatesha, V.A., Parsels, L.A., Parsels, J.D., Zhao, L., Zabludoff, S.D., Simeone, D.M., Maybaum, J., Lawrence, T.S., and Morgan, M.A. (2012). Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. Neoplasia 14, 519-525. DOI |
5 | Vinogradov, S., and Wei, X. (2012). Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine 7, 597-615. DOI |
6 | Wang, H., Zhang, G., Zhang, H., Zhang, F., Zhou, B., Ning, F., Wang, H.S., Cai, S.H., and Du, J. (2014). Acquisition of epithelialmesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/beta-catenin/Snail signaling pathway. Eur. J. Pharmacol. 723, 156-166. DOI ScienceOn |
7 | Zhang, Y., Ng, H.H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. (1999). Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935. DOI ScienceOn |
8 | Liu, A.Y., Cai, Y., Mao, Y., Lin, Y., Zheng, H., Wu, T., Huang, Y., Fang, X., Lin, S., Feng, Q., et al. (2014). Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. Carcinogenesis 35, 537-545. DOI ScienceOn |
9 | Morais, C., Gobe, G., Johnson, D.W., and Healy, H. (2010). Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma. Apoptosis 15, 412-425. DOI |
10 | Ma, B.B., Lui, V.W., Hui, E.P., Lau, C.P., Ho, K., Ng, M.H., Cheng, S.H., Tsao, S.W., and Chan, A.T. (2010). The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines. Invest. New Drugs 28, 413-420. DOI |
11 | Nagaraj, S.R., Shilpa, P., Rachaiah, K., and Salimath, B.P. (2013). Crosstalk between VEGF and MTA1 signaling pathways contrib-ute to aggressiveness of breast carcinoma. Mol. Carcinog. [Epub ahead of print]. |
12 | Reddy, S.D., Pakala, S.B., Molli, P.R., Sahni, N., Karanam, N.K., Mudvari, P., and Kumar, R. (2012). Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function. J. Biol.Chem. 287, 27843-27850. DOI |
13 | Salot, S., and Gude, R. (2013). MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines. Eur. J.Cancer 49, 492-499. DOI ScienceOn |
14 | Serin, M., Erkal, H.S., and Cakmak, A. (1999). Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas. Acta Oncol. 38, 1031-1035. DOI |
15 | Shafee, N., Smith, C.R., Wei, S., Kim, Y., Mills, G.B., Hortobagyi, G.N., Stanbridge, E.J., and Lee, E.Y. (2008). Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Res. 68, 3243-3250. DOI ScienceOn |
16 | Kumar, R., Wang, R.A., and Bagheri-Yarmand, R. (2003). Emerging roles of MTA family members in human cancers. Semi.Oncol. 30, 30-37. DOI |
17 | Barr, M.P., Gray, S.G., Hoffmann, A.C., Hilger, R.A., Thomale, J., O’Flaherty, J.D., Fennell, D.A., Richard, D., O’Leary, J.J., and O’Byrne, K.J. (2013). Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS One 8, e54193. DOI |
18 | Bui-Nguyen, T.M., Pakala, S.B., Sirigiri, R.D., Xia, W., Hung, M.C., Sarin, S.K., Kumar, V., Slagle, B.L., and Kumar, R. (2010). NFkappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene 29, 1179-1189. DOI ScienceOn |
19 | Godwin, P., Baird, A.M., Heavey, S., Barr, M.P., O'Byrne, K.J., and Gately, K. (2013). Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Front.Oncol. 3, 120. |
20 | Kumar, R., Balasenthil, S., Pakala, S.B., Rayala, S.K., Sahin, A.A., and Ohshiro, K. (2010). Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells. Cancer Res. 70, 6598-6608. DOI ScienceOn |
21 | Li, D.Q., Pakala, S.B., Nair, S.S., Eswaran, J., and Kumar, R. (2012a). Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res. 72, 387-394. DOI |
22 | Donnenberg, V.S., and Donnenberg, A.D. (2005). Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J.Clin.Pharmacol. 45, 872-877. DOI |
23 | Li, Y., Huang, W., Huang, S., Du, J., and Huang, C. (2012b). Screening of anti-cancer agent using zebrafish: comparison with the MTT assay. Biochem.Biophys.Res.Commun. 422, 85-90. DOI ScienceOn |
24 | Ma, L., Zhang, G., Miao, X.B., Deng, X.B., Wu, Y., Liu, Y., Jin, Z.R., Li, X.Q., Liu, Q.Z., Sun, D.X., et al. (2013). Cancer stem-like cell properties are regulated by EGFR/AKT/beta-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma. FEBS J. 280, 2027-2041. DOI ScienceOn |